Literature DB >> 26182315

JAMA Oncology Patient Page. Immune Checkpoint Inhibitors.

Howard Jack West.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26182315     DOI： 10.1001/jamaoncol.2015.0137

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  9 in total

1.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

2.  Xp11.2 translocation renal cell carcinoma with TFE3 gene fusion in the elderly: case report and literature review.

Authors:  Toshihiko Masago; Susumu Kobayakawa; Yuu Ohtani; Kenjirou Taniguchi; Takuji Naka; Naoto Kuroda; Chihiro Takahashi; Tadahiro Isoyama; Takehiro Sejima
Journal:  Int Cancer Conf J       Date:  2020-07-08

3.  Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade.

Authors:  Carlos Gomez-Roca; Philippe Cassier; Dmitriy Zamarin; Jean-Pascal Machiels; Jose Luis Perez Gracia; F Stephen Hodi; Alvaro Taus; Maria Martinez Garcia; Valentina Boni; Joseph P Eder; Navid Hafez; Ryan Sullivan; David Mcdermott; Stephane Champiat; Sandrine Aspeslagh; Catherine Terret; Anna-Maria Jegg; Wolfgang Jacob; Michael A Cannarile; Carola Ries; Konstanty Korski; Francesca Michielin; Randolph Christen; Galina Babitzki; Carl Watson; Georgina Meneses-Lorente; Martin Weisser; Dominik Rüttinger; Jean-Pierre Delord; Aurelien Marabelle
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

4.  Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers.

Authors:  Vivek Subbiah; Ravi Murthy; David S Hong; Robert M Prins; Chitra Hosing; Kyle Hendricks; Deepthi Kolli; Lori Noffsinger; Robert Brown; Mary McGuire; Siquing Fu; Sarina Piha-Paul; Aung Naing; Anthony P Conley; Robert S Benjamin; Indreshpal Kaur; Marnix L Bosch
Journal:  Clin Cancer Res       Date:  2018-07-17       Impact factor: 12.531

Review 5.  Viroimmunotherapy for Colorectal Cancer: Clinical Studies.

Authors:  Shyambabu Chaurasiya; Susanne Warner
Journal:  Biomedicines       Date:  2017-03-10

6.  Monitoring Endocrine Complications of Immunotherapy: A Screening Tool.

Authors:  Priyanka Majety; Anna Groysman; Virginia Seery; Meghan Shea; Runhua Hou
Journal:  Cureus       Date:  2022-07-14

7.  Computational Biology Predicts the Efficacy of Tumor Immune Checkpoint Blockade.

Authors:  Wenyi Kang; Yao Tong; Weijia Zhang; Mengru Jian; Anqi Zhang; Guoqing Ren; Hao Fan; Jiyuan Yang
Journal:  Biomed Res Int       Date:  2022-09-28       Impact factor: 3.246

8.  Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.

Authors:  Houssein Safa; Monica Tamil; Philippe E Spiess; Brandon Manley; Julio Pow-Sang; Scott M Gilbert; Firas Safa; Brian D Gonzalez; Laura B Oswald; Adele Semaan; Adi Diab; Jad Chahoud
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506

9.  Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.

Authors:  Alyson Haslam; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2019-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.